Novel lipoxygenase inhibitors

Details for Australian Patent Application No. 2005328327 (hide)

Owner Galileo Pharmaceuticals, Inc.

Inventors Zhang, Wei; Chen, Jian

Agent Spruson & Ferguson

Pub. Number AU-A-2005328327

PCT Pub. Number WO2006/093547

Priority 60/656,644 25.02.05 US

Filing date 9 December 2005

Wipo publication date 8 September 2006

International Classifications

C07D 207/10 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

C07D 211/60 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Event Publications

6 September 2007 PCT application entered the National Phase

  PCT publication WO2006/093547 Priority application(s): WO2006/093547

7 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005328328-Spiro-heterocyclic chromans, thiochromans and dihydroquinolines

2005328325-Activating extraction of demineralized bone matrix